Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children

From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the risk of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariani, Marcello, Caorsi, Roberta, Consolaro, Alessandro, Brisca, Giacomo, Sticchi, Camilla, Gattorno, Marco, Castagnola, Elio, Ravelli, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354361/
https://www.ncbi.nlm.nih.gov/pubmed/35927681
http://dx.doi.org/10.1186/s13052-022-01335-1
_version_ 1784763052903628800
author Mariani, Marcello
Caorsi, Roberta
Consolaro, Alessandro
Brisca, Giacomo
Sticchi, Camilla
Gattorno, Marco
Castagnola, Elio
Ravelli, Angelo
author_facet Mariani, Marcello
Caorsi, Roberta
Consolaro, Alessandro
Brisca, Giacomo
Sticchi, Camilla
Gattorno, Marco
Castagnola, Elio
Ravelli, Angelo
author_sort Mariani, Marcello
collection PubMed
description From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the risk of myocarditis after COVID-19 vaccine.
format Online
Article
Text
id pubmed-9354361
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93543612022-08-06 Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children Mariani, Marcello Caorsi, Roberta Consolaro, Alessandro Brisca, Giacomo Sticchi, Camilla Gattorno, Marco Castagnola, Elio Ravelli, Angelo Ital J Pediatr Letter to the Editor From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the risk of myocarditis after COVID-19 vaccine. BioMed Central 2022-08-04 /pmc/articles/PMC9354361/ /pubmed/35927681 http://dx.doi.org/10.1186/s13052-022-01335-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Mariani, Marcello
Caorsi, Roberta
Consolaro, Alessandro
Brisca, Giacomo
Sticchi, Camilla
Gattorno, Marco
Castagnola, Elio
Ravelli, Angelo
Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
title Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
title_full Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
title_fullStr Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
title_full_unstemmed Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
title_short Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
title_sort protection against mis-c outweighs the risk of myocarditis after covid-19 vaccination in children
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354361/
https://www.ncbi.nlm.nih.gov/pubmed/35927681
http://dx.doi.org/10.1186/s13052-022-01335-1
work_keys_str_mv AT marianimarcello protectionagainstmiscoutweighstheriskofmyocarditisaftercovid19vaccinationinchildren
AT caorsiroberta protectionagainstmiscoutweighstheriskofmyocarditisaftercovid19vaccinationinchildren
AT consolaroalessandro protectionagainstmiscoutweighstheriskofmyocarditisaftercovid19vaccinationinchildren
AT briscagiacomo protectionagainstmiscoutweighstheriskofmyocarditisaftercovid19vaccinationinchildren
AT sticchicamilla protectionagainstmiscoutweighstheriskofmyocarditisaftercovid19vaccinationinchildren
AT gattornomarco protectionagainstmiscoutweighstheriskofmyocarditisaftercovid19vaccinationinchildren
AT castagnolaelio protectionagainstmiscoutweighstheriskofmyocarditisaftercovid19vaccinationinchildren
AT ravelliangelo protectionagainstmiscoutweighstheriskofmyocarditisaftercovid19vaccinationinchildren

Ejemplares similares